Most Recent Publications

The Keri Lab has a record of publishing research in high-impact peer-reviewed journals. Below are the 5 most recent publications from our lab. The National Center for Biotechnology Information contains an up-to-date list of all of our publications


The transcriptional repressor BCL11A promotes breast cancer metastasis. Seachrist DD, Hannigan MM, Ingles NN, Webb BM, Weber-Bonk KL, Yu P, Bebek G, Singh S, Sizemore ST, Varadan V, Licatalosi DD, Keri RA. J Biol Chem. 2020 Jun 23. doi:10.1074/jbc.RA120.014018.

KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene. Roberts MS, Anstine LJ, Finke VS, Bryson BL, Webb BM, Weber-Bonk KL, Seachrist DD, Majmudar PR, Keri RA. Breast Cancer Res. 2020 Jun 18. doi: 10.1186/s13058-020-01305-7.

LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance. Roberts MS, Sahni JM, Schrock MS, Piemonte KM, Weber-Bonk KL, Seachrist DD, Avril S, Anstine LJ, Singh S, Sizemore ST, Varadan V, Summers MK, Keri RA. Cancer Res. 2020 Feb 13. doi:10.1158/0008-5472.CAN-19-3466.

A new view of the mammary epithelial hierarchy and its implications for breast cancer initiation and metastasis. Anstine LJ, Keri RA. J Cancer Metastasis Treat. 2019 Jun 13. doi: 10.20517/2394-4722.2019.24.

The Activin Social Network: Activin, Inhibin and Follistatin in Breast Development and Cancer. Seachrist DD, Keri RA. Endocrinology. 2019 Mar 15; 160(5):1097-1110. doi: 10.1210/en.2019-00015.